Quick Answer
GOLDENWELL BIOTECH, INC. reported Total Assets of $224.2 thousand for the year ending 2024.
- GOLDENWELL BIOTECH, INC. showed a decrease of -1.7% in Total Assets from 2023 to 2024.
- This data is from GOLDENWELL BIOTECH, INC.'s annual report (Form 10-K), filed with the SEC on May 15, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $250.5 thousand | Q1 2021: $435.2 thousand | Q2 2021: $509.2 thousand | Q3 2021: $485.8 thousand | Q1 2022: $308.7 thousand | Q2 2022: $274.4 thousand | Q3 2022: $266.1 thousand | Q1 2023: $219.4 thousand | Q2 2023: $192.3 thousand | Q3 2023: $186.9 thousand | Q1 2024: $199.0 thousand | Q2 2024: $200.4 thousand | Q3 2024: $179.4 thousand | Q4 2024: $224.2 thousand | Q1 2025: $191.9 thousand | Q2 2025: $251.3 thousand | Q3 2025: $220.4 thousand.
- Over the full 6 years of available data (2019 to 2024), GOLDENWELL BIOTECH, INC.'s Total Assets has declined by 9.1%.
- Historical annual values: Fiscal year 2024: $224.2 thousand | Fiscal year 2023: $228.1 thousand | Fiscal year 2022: $248.4 thousand | Fiscal year 2021: $461.0 thousand | Fiscal year 2020: $248.6 thousand | Fiscal year 2019: $246.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: